<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="101008">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02150759</url>
  </required_header>
  <id_info>
    <org_study_id>2014-027</org_study_id>
    <nct_id>NCT02150759</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine-ketamine in Femur Proximal Fracture Patients</brief_title>
  <official_title>Comparison Study of Analgesic Effects for Dexmedetomidine-fentanyl vs Dexmedetomidine-ketamine in Femur Proximal Fracture Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <authority>South Korea: Ministry of Food and Drug Safety</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Comparison study of analgesic effects for dexmedetomidine-fentanyl vs
           dexmedetomidine-ketamine

        -  lateral position for spinal anesthesia in femur proximal fracture patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Dexmedetomidine (1mcg/kg)- fentanyl (1mcg/kg) vs dexmedetomidine (1mcg/kg) - ketamine
           (1mg/kg) 10 minutes loading.

        -  After 10 minutes of drug infusion, patients are prepared for spinal anesthesia.

        -  pain scale and quality of patient positioning are measured three times (lateral
           position, chest-knee position, intrathecal local anesthetics injection)

        -  When patients have severe pain during intraoperative period, fentanyl 50 mcg will be
           intravenously inject.

        -  Patients will be injected propofol 10mg when they have agitation signs during
           operation.

        -  vital signs, bispectral index, korean version of mini mental status examination, verbal
           rating scale,fentany/propofol consumption, frequency of intrathecal injection
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Pain score using five scales</measure>
    <time_frame>average 10-20 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>We want to compare pain score (five scales; 0=calm, 1=facial grimacing, 2=moaning, 3=screaming, 4=restlessness or agitation, unable to proceed) when patients are lateral position during spinal anesthesia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of patient positioning</measure>
    <time_frame>average 10-20 minutes during spinal anesthesia</time_frame>
    <safety_issue>No</safety_issue>
    <description>We estimate quality of patient positioning (0=not satisfactory, 1=satisfactory, 2=good, 3=optimal) during spinal anesthesia between two groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">46</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine-ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine-ketamine group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine-fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexmedetomidine-fentanyl group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>dexmedetomidine infusion during spinal anesthesia</description>
    <arm_group_label>Dexmedetomidine-ketamine</arm_group_label>
    <arm_group_label>Dexmedetomidine-fentanyl</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>add dexmedetomidine during position change</description>
    <arm_group_label>Dexmedetomidine-fentanyl</arm_group_label>
    <other_name>fentanyl citrate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>add dexmedetomidine during position change</description>
    <arm_group_label>Dexmedetomidine-ketamine</arm_group_label>
    <other_name>ketamine HCl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American society of anesthesiologists classification 1-3 patients

          -  &gt;20 years old

        Exclusion Criteria:

          -  patients refuse

          -  dementia patients, cooperation difficult patients

          -  anaphylaxis of dexmedetomidine, ketamine, local anesthetics

          -  heart problem (bradycardia, atrioventricular block)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang Eun Lee, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ki Hwa Lee, MD</last_name>
    <phone>82-51-797-0426</phone>
    <email>tedy333@paik.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sang eun Lee, MD</last_name>
    <phone>82-51-797-0425</phone>
    <email>104480@paik.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Haeundae paik hospital, inje university</name>
      <address>
        <city>Busan</city>
        <zip>612-896</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ki Hwa Lee, MD</last_name>
      <phone>82-51-797-0426</phone>
      <email>tedy333@paik.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Ki Hwa Lee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 27, 2014</lastchanged_date>
  <firstreceived_date>May 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Ki Hwa Lee</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Ketamine</keyword>
  <keyword>Pain</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
